• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Genetic Analysis

0.64 NOK

Less than 1K followers

GEAN

Spotlight Stock Market

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
-1.54 %
-0.62 %
+4.92 %
-8.57 %
-12.93 %
-34.69 %
-62.35 %
-
-94.02 %

Genetic Analysis operates in the medical technology sector. The company conducts research and development in the field of diagnostics, with the greatest focus on the human microbiome. The technology is based on the company's research platform and the IVD products are used, for example, for testing and analysis of bacteria and viruses. The largest operations are found in the Nordic market and the products are mainly resold to laboratories. The company is headquartered in Oslo, Norway.

Read more
Market cap
44.22M NOK
Turnover
-
Revenue
16.71M
EBIT %
-67.4 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
28/8
2026

Interim report Q2'26

26/11
2026

Interim report Q3'26

25/2
2027

Annual report '26

Press release6/5/2026, 11:50 AM

Analyst Group: Equity Research Report on Genetic Analysis - Strong Momentum in a Growing Microbiome Market

Genetic Analysis
Press release5/28/2026, 2:22 PM

Analyst Group: Analyst Group Comment on Genetic Analysis Q1-report Report 2026

Genetic Analysis
Regulatory press release5/28/2026, 6:45 AM

Publication of interim report January - March 2026

Genetic Analysis

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release5/20/2026, 3:00 PM

Genetic Analysis AS: Minutes of Annual General Meeting

Genetic Analysis
Regulatory press release5/7/2026, 8:00 AM

Genetic Analysis AS: Genetic Analysis granted a U.S. patent for companion diagnostic related to IBS treatment response

Genetic Analysis
Regulatory press release5/5/2026, 7:00 AM

Genetic Analysis AS: Notice of annual general meeting

Genetic Analysis
Regulatory press release5/4/2026, 12:30 PM

Genetic Analysis AS publishes Annual Report 2025

Genetic Analysis
Press release4/30/2026, 8:00 AM

Genetic Analysis AS: Genetic Analysis to attend DDW congress in Chicago

Genetic Analysis
Press release3/12/2026, 10:38 AM

Analyst Group: Analyst Group Comments on Genetic Analysis Launch of GA-map® Dysbiosis Test AInsight

Genetic Analysis
Regulatory press release3/12/2026, 7:00 AM

Genetic Analysis AS launches AInsight for AI-assisted interpretation of GA-map® Dysbiosis Test results

Genetic Analysis
Press release3/5/2026, 3:00 PM

Analyst Group: Analyst Group Interview Genetic Analysis CEO Ronny Hermansen

Genetic Analysis
Press release3/4/2026, 10:28 AM

Analyst Group: Equity Research Report on Genetic Analysis - Sustained Long-Term Growth Outlook Supported by Platform Strategy

Genetic Analysis
Press release2/27/2026, 12:44 PM

Analyst Group: Analyst Group Comment on Genetic Analysis Q4-report Report 2025

Genetic Analysis
Regulatory press release2/27/2026, 7:45 AM

Genetic Analysis AS: Publication of year-end report 2025

Genetic Analysis
Regulatory press release2/26/2026, 3:10 PM

Genetic Analysis AS: Clarification regarding the publication date of the year-end report 2025

Genetic Analysis
Regulatory press release2/19/2026, 7:00 AM

Genetic Analysis AS further strengthens IP portfolio with patent approval in the United States

Genetic Analysis
Regulatory press release2/12/2026, 8:00 AM

Genetic Analysis AS: Microbiome Dx Genetic Analysis announces important patent approval enhancing the use of GA-map® in Canada

Genetic Analysis
Press release12/5/2025, 9:45 AM

Analyst Group: Equity Research Report on Genetic Analysis - Expands the Product Portfolio

Genetic Analysis
Press release11/27/2025, 12:33 PM

Analyst Group: Analyst Group Comment on Genetic Analysis Q3-report Report 2025

Genetic Analysis
Regulatory press release11/27/2025, 7:00 AM

Genetic Analysis AS: Publication of interim report Q3 2025

Genetic Analysis